How much has Immunomatics raised?

Immunomatics has raised $100K in one sourced round on record (Seed), announced October 6, 2026.

Who invested in Immunomatics?

Investors on record for Immunomatics: Myosotis Investments and National Institutes of Health. Myosotis Investments led its latest sourced round.

Who founded Immunomatics?

Immunomatics was founded by Lidio Meireles (Founder & CEO).

Where is Immunomatics based?

Immunomatics is based in San Marcos, United States.

Immunomatics

Immunomatics is a healthtech company developing AI software to predict donor-recipient compatibility risk.

Health and bio

Latest funding

$100K Seed · October 6, 2026

Led by Myosotis Investments · Source: prnewswire.com

Funding history ↓

Website: immunomatics.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Artificial Intelligence (AI), Biotechnology.

Stage: Seed.

Based in: San Marcos, United States.

Last round: Oct 6, 2026 · 18 days ago.

Domain age: 2 years.

On Recent Funding since: Oct 8, 2026.

About Immunomatics

Immunomatics is a company based in San Marcos, United States. Recent Funding lists it under Health and bio. It raised $100K in a Seed round in October 2026, led by Myosotis Investments, according to prnewswire.com. Investors on record include National Institutes of Health. It was founded by Lidio Meireles.

Funding rounds

October 6, 2026
Seed · $100K
MMyosotis Investments (lead)
Source: prnewswire.com
March 9, 2024
Website created

Founders and team

LM
Lidio Meireles Founder & CEO

source: immunomatics.com

Investors

Similar Health and bio companies

PPathos$237M Series B+ · Oct 2026
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
SStar Therapeutics$200M Series B+ · Oct 2026

Questions and sources

Immunomatics: questions and answers

How much has Immunomatics raised?: Immunomatics has raised $100K in one sourced round on record (Seed), announced October 6, 2026.
Who invested in Immunomatics?: Investors on record for Immunomatics: Myosotis Investments and National Institutes of Health. Myosotis Investments led its latest sourced round.
Who founded Immunomatics?: Immunomatics was founded by Lidio Meireles (Founder & CEO).
Where is Immunomatics based?: Immunomatics is based in San Marcos, United States.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/immunomatics (get a free API key).